VeriMomБезопасен ли asiaticoside при беременности?
No harmonised CLP reproductive classification found for asiaticoside (CAS 16830-15-2). Regulatory/authoritative safety assessments (CIR/SCCS/Harmonised CLP) do not list reproductive hazards for asiaticoside, and peer‑reviewed literature reports pharmacology (wound healing/dermatologic effects) rather than reproductive toxicity (PubMed, PubChem). Therefore default hazard/mechanism/exposure scores are 0. Sources consulted: PubChem, PubMed, ECHA/CosIng listings; no CIR or SCCS reproductive concerns identified.
Pregnancy-safe products containing asiaticoside
Related ingredients
Frequently asked questions
- Безопасен ли asiaticoside при беременности?
- No harmonised CLP reproductive classification found for asiaticoside (CAS 16830-15-2). Regulatory/authoritative safety assessments (CIR/SCCS/Harmonised CLP) do not list reproductive hazards for asiaticoside, and peer‑reviewed literature reports pharmacology (wound healing/dermatologic effects) rather than reproductive toxicity (PubMed, PubChem). Therefore default hazard/mechanism/exposure scores are 0. Sources consulted: PubChem, PubMed, ECHA/CosIng listings; no CIR or SCCS reproductive concerns identified.
- Безопасен ли asiaticoside при грудном вскармливании?
- No evidence in regulatory databases or peer‑reviewed literature that asiaticoside causes reproductive or lactation-related toxicity or systemic maternal effects that would contraindicate breastfeeding. Asiaticoside is a relatively large polar glycoside (limited oral/topical systemic bioavailability reported in dermal contexts), and no demonstrated mechanism for transfer into breast milk was identified (PubMed, PubChem, ECHA/CosIng).
- Безопасен ли asiaticoside для кожи малыша?
- No reproductive/toxic effects specific to infants were identified. Given asiaticoside is a triterpenoid glycoside with limited reported systemic absorption after topical application, hazard and mechanistic scores remain 0. Exposure score raised to 1 for 0–3 yr skin because immature barrier and higher surface‑area‑to‑weight can increase percutaneous uptake (general dermal pharmacokinetic principle); however no data show significant systemic exposure in infants.
- Как VeriMom оценивает asiaticoside?
- VeriMom оценивает asiaticoside в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы asiaticoside при беременности?
- См. наш список безопасных альтернатив asiaticoside с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.